Fibromyalgia, Sjogren’s & depression: linked?

References

• Mehrotra A, Forrest CB, Lin CY. Dropping the baton: specialty referrals in the United States. Milbank Q. 2011;89(1):39–68.
   PubMed Web of Science ®Google Scholar
• Starfield B, Forrest CB, Nutting PA, et al. Variability in physician referral decisions. J Am Board Fam Pract. 2002;15(6):473–480.
   PubMedGoogle Scholar
• Pelizza L, Bonacini F, Ferrari A. Psychiatric disorder as clinical presentation of primary Sjogren’s syndrome: two case reports. Ann Gen Psych. 2010;9(12):1–4.
   Google Scholar
• CDC. Fibromyalgia: US department of health and Human Services. 2018 [cited 2020 Apr 5]. Available from: https://www.cdc.gov/arthritis/basics/fibromyalgia.htm
   Google Scholar
• Association NF Prevalence of Fibromyalgia; 2018. [cited 2020 Apr 5]. Available from: http://www.fmaware.org/about-fibromyalgia/prevalence/
   Google Scholar
• Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol. 2014;6:247–255.
   PubMed Web of Science ®Google Scholar
• Birlik M, Akar S, Gurler O, et al. Prevalence of primary Sjogren’s syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract. 2009;63(6):954–961.
   PubMed Web of Science ®Google Scholar
• Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547:1–12.
   PubMed Web of Science ®Google Scholar
• NIMH. Prevalence of Major depressive episode among adults: the National institute of mental health. 2016 [cited 2020 Apr 5] Available from: https://www.nimh.nih.gov/health/statistics/major-depression.shtml
   Google Scholar
• Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psych. 2003;64(12):1465–1475.
   Google Scholar
• Gracely RH, Ceko M, Bushnell MC. Fibromyalgia and Depression. Pain Res Treat. 2012;9:1–9.
   Google Scholar
• Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–2445.
   PubMed Web of Science ®Google Scholar
• Valtysdottir ST, Gudbjornsson B, Lindqvist U, et al. Anxiety and depression in patients with primary Sjogren’s syndrome. J Rheumatol. 2000;27(1):165–169.
   PubMed Web of Science ®Google Scholar
• Choi BY, Oh HJ, Lee YJ, et al. Prevalence and clinical impact of fibromyalgia in patients with primary Sjogren’s syndrome. Clin Exp Rheumatol. 2016;34(2 Suppl 96):S9–13.
   PubMed Web of Science ®Google Scholar
• Cui Y, Li L, Yin R, et al. Depression in primary Sjogren’s syndrome: a systematic review and meta-analysis. Psychol Health Med. 2018;23(2):198–209.
   PubMed Web of Science ®Google Scholar
• Cui Y, Xia L, Li L, et al. Anxiety and depression in primary Sjogren’s syndrome: a cross-sectional study. BMC Psych. 2018;18(131):1–8.
   PubMedGoogle Scholar
• Sun X, Lu L, Li Y, et al. Increased risk of thyroid disease in patients with Sjogren’s syndrome: a systematic review and meta-analysis. PeerJ. 2019;7(e6737):1–13.
   Google Scholar
• Baldini C, Ferro F, Mosca M, et al. The association of Sjögren syndrome and autoimmune thyroid disorders. Front Endocrinol (Lausanne). 2018;9(121):1–5.
   PubMedGoogle Scholar
• Jara ZJ, Navarro C, Brito-Zerón MP, et al. Thyroid disease in Sjögren’s syndrome. Clin Rheumatol. 2007;26:1601–1606.
   PubMed Web of Science ®Google Scholar
• Bourji K, Gatto M, Cozzi F, et al. Rheumatic and autoimmune thyroid disorders: a causal or casual relationship. Autoimmun Rev. 2015;14(1):57–63.
   PubMed Web of Science ®Google Scholar
• Milic V, Radunovic G, Boricic I, et al. High prevalence of autoimmune thyroid disease in subjects with sicca symptoms without Sjogren’s syndrome. Rheumatology. 2013;52(4):754–755.
   PubMed Web of Science ®Google Scholar
• Van Houdenhove B, Egle UT. Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together. Psychother Psychosom. 2004;73(5):267–275.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Jones J, Turk DC, et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8(27):1–11.
   PubMedGoogle Scholar
• Duman RS, Aghajanian GK, Sanacora G, et al. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22(3):238–249.
   PubMed Web of Science ®Google Scholar
• Thiagarajah AS, Guymer EK, Leech M, et al. The relationship between fibromyalgia, stress and depression. Int J Clin Rheumatol. 2014;9(4):371–384.
   Google Scholar
• Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37(11):1583–1592.
   PubMed Web of Science ®Google Scholar
• Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 2006;8(4):383–395.
   PubMedGoogle Scholar
• Lü YF, Yang Y, Li CL, et al. The locus coeruleus-norepinephrine system mediates empathy for pain through selective up-regulation of P2X3 receptor in dorsal root ganglia in rats. Front Neural Circuits. 2017;11(66):1–15.
   PubMedGoogle Scholar
• Bird AK, Meednu N, Anolik JH. New insights into B cell biology in systemic lupus erythematosus and Sjögren’s syndrome. Curr Opin Rheumatol. 2015;27(5):461–467.
   PubMed Web of Science ®Google Scholar
• Both T, Dalm VA, van Hagen PM, et al. Reviewing primary Sjögren’s syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment. Int J Med Sci. 2017;14(3):191–200.
   PubMed Web of Science ®Google Scholar
• Brkic Z, Maria NI, van Helden-meeuwsen CG, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren’s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis. 2013;72(5):728–735.
   PubMed Web of Science ®Google Scholar
• Karageorgas T, Fragioudaki S, Nezos A, et al. Fatigue in primary Sjögren’s Syndrome: clinical, laboratory, psychometric, and biologic associations. Arthritis Care Res (Hoboken). 2016;68:123–131.
   PubMed Web of Science ®Google Scholar
• Miyamoto ST, Lendrem DW, Ng WF, et al. Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions. Open Access Rheumatol. 2019;11:77–88.
   PubMed Web of Science ®Google Scholar
• Skopouli FN, Katsiougiannis S. How stress contributes to autoimmunity-lessons from Sjögren’s syndrome. Fed Eur Biochem Soc Lett. 2018 01;592(1):5–14.
   PubMed Web of Science ®Google Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34.
   PubMed Web of Science ®Google Scholar
• Fenoglio KA, Brunson KL, Baram TZ. Hippocampal neuroplasticity induced by early-life stress: functional and molecular aspects. Front Neuroendocrinol. 2006;27(2):180–192.
   PubMed Web of Science ®Google Scholar
• Cohen-Cory S, Kidane AH, Shirkey NJ, et al. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 2010;70(5):271–288.
   PubMed Web of Science ®Google Scholar
• Menard C, Hodes GE, Russo SJ. Pathogenesis of depression: insights from human and rodent studies. Neuroscience. 2016;321:138–162.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. report of the multicenter criteria committee. Arthritis Rheum. 1990;33(2):160–172.
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, Boulos P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatol (Oxford). 2003;42(2):263–267.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–329.
   PubMed Web of Science ®Google Scholar
• Rasmussen A, Ice JA, Li H, et al. Comparison of the American-European consensus group Sjogren’s syndrome classification criteria to newly proposed American college of rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis. 2014;73(1):31–38.
   PubMed Web of Science ®Google Scholar
• Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: classification and criteria changes. World Psych. 2013;12(2):92–98.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Choy E, Clauw DJ, et al. Fibromyalgia and chronic pain syndromes: a white paper detailing current challenges in the field. Clin J Pain. 2016;32(9):737–746.
   PubMed Web of Science ®Google Scholar
• Tincani A, Andreoli L, Cavazzana I, et al. Novel aspects of Sjögren’s syndrome in 2012. BMC Med. 2013;11(1):93:1–7.
   PubMedGoogle Scholar
• Ienopoli S, Carsons SE. Extraglandular manifestations of primary Sjögren’s syndrome. Oral Maxillofac Surg Clin North Am. 2014;26(1):91–99.
   PubMed Web of Science ®Google Scholar
• Gudbjörnsson B, Broman JE, Hetta J, et al. Sleep disturbances in patients with primary Sjögren’s syndrome. Br J Rheumatol. 1993;32(12):1072–1076.
   PubMedGoogle Scholar
• Fragkioudaki S, Mavragani CP, Moutsopoulos HM. Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use. Med (Baltimore). 2016;95(25):e3766:1–8.
   PubMed Web of Science ®Google Scholar
• NIMH. Overview of depression: national institute of mental health; 2019 [cited 2020 Apr 5]. Available from: https://www.nimh.nih.gov/health/topics/depression/index.shtml
   Google Scholar
• Association AP. What is depression: APA; 2019 [cited 2020 Apr 5]. Available from: https://www.psychiatry.org/patients-families/depression/what-is-depression
   Google Scholar
• Force USPST. Final Recommendation Statement Depression in Adults: screening: USPSTF. 2019 [cited 2020 Apr 5]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-adults-screening
   Google Scholar
• Lopez-Torres J, Parraga I, Del Campo JM, et al. Follow up of patients who start treatment with antidepressants: treatment satisfaction, treatment compliance, efficacy and safety. BMC Psych. 2013;13(65):1–9.
   PubMedGoogle Scholar
• Vivino FB, Carsons SE, Foulks G, et al. New treatment guidelines for Sjögren’s disease. Rheum Dis Clin North Am. 2016;42(3):531–551.
   PubMed Web of Science ®Google Scholar
• Kia S, Choy E. Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomed. 2017;5(2):1–24.
   Google Scholar
• Cascade EF, Kalali AH, Nihalani ND, et al. Treatment of fibromyalgia. Psych (Edgmont). 2008;5(3):18–21.
   PubMedGoogle Scholar
• Cooper TE, Derry S, Wiffen PJ, et al. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;1(Cd012188):1–31.
   Google Scholar
• Goldenberg DL, Clauw DJ, Palmer RE, et al. Opioid use in fibromyalgia: a cautionary tale. Mayo Clin Proc. 2016;91(5):640–648.
   PubMed Web of Science ®Google Scholar
• Kress HG, Aldington D, Alon E, et al. A holistic approach to chronic pain management that involves all stakeholders: change is needed. Curr Med Res Opin. 2015;31(9):1743–1754
   PubMed Web of Science ®Google Scholar